South Korea has attracted increasing investment from the pharmaceutical industry, which is drawn to the Asian country due to its experience in antibody-drug conjugates and cell and gene therapies, according to McKinsey.
Roche Broadens Global Clinical Trial Footprint With $480M+ South Korea Pledge